These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26603069)

  • 1. Is Long-Term Anti-Osteoporotic Treatment Associated with Greater Risk of Cancer in People with Severe Vertebral Fractures? A Hospital-Based Cohort Study.
    Chen YC; Su FM; Cheng TT; Lai HM; Yu SF
    J Am Geriatr Soc; 2015 Nov; 63(11):2418-9. PubMed ID: 26603069
    [No Abstract]   [Full Text] [Related]  

  • 2. Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice.
    Oswald AJ; Berg J; Milne G; Ralston SH
    Calcif Tissue Int; 2014 Feb; 94(2):176-82. PubMed ID: 24026567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alendronate for treatment of osteoporoses].
    Harada A
    Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
    Lin TC; Lee CH; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1599-607. PubMed ID: 24606074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical vertebral fractures following denosumab discontinuation.
    Polyzos SA; Terpos E
    Endocrine; 2016 Oct; 54(1):271-272. PubMed ID: 27393301
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of repeated and multiple new-onset osteoporotic vertebral compression fractures with teriparatide.
    Tu PH; Liu ZH; Lee ST; Chen JF
    J Clin Neurosci; 2012 Apr; 19(4):532-5. PubMed ID: 22341147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four cases.
    Challal S; Semerano L; Nunes H; Valeyre D; Boissier MC; Saidenberg-Kermanac'h N
    Joint Bone Spine; 2016 May; 83(3):344-5. PubMed ID: 26709249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Process in development of PTH, an awaited bone-density conservation agent].
    Sugimoto T
    Clin Calcium; 2012 Mar; 22(3):307. PubMed ID: 22893932
    [No Abstract]   [Full Text] [Related]  

  • 11. [Osteoporotic fractures: not only in females].
    Abetel G; Ferrari S
    Rev Med Suisse; 2014 Apr; 10(424):767-8. PubMed ID: 24772811
    [No Abstract]   [Full Text] [Related]  

  • 12. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
    McCarus DC
    Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistent osteoporosis and multiple myeloma: when to investigate further in osteoporosis.
    Mumford ER; Raffles S; Reynolds P
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26452412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichenoid dermatosis induced by alendronate: an unusual skin drug reaction.
    Husein-Elahmed H; Aneiros-Fernandez J; Arias-Santiago S; Aneiros-Cachaza J; Naranjo-Sintes R
    Acta Derm Venereol; 2010 May; 90(3):309-10. PubMed ID: 20526558
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
    Wynn RL
    Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
    [No Abstract]   [Full Text] [Related]  

  • 17. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.
    Ringe JD; Schacht E; Dukas L; Mazor Z
    Arzneimittelforschung; 2011; 61(2):104-11. PubMed ID: 21428245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring bone turnover markers during treatment with the anabolic agent teriparatide; in particular, treatment using daily and weekly subucutaneous injections].
    Miyauchi A
    Clin Calcium; 2012 Mar; 22(3):387-98. PubMed ID: 22370306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.